Amedica and Celling Biosciences to Collaborate on Spinal Fusion Devices

Amedica and Celling Biosciences will co-develop biologically-enhanced spinal fusion devices based on silicon nitride technology plus stem cell-based therapies.

Thus far, Celling Biosciences' in vivo research indicates that mesenchymal stem cells may be optimized and proliferate when using silicon nitride vs. PEEK and titanium...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us